JAK2 617V>F positive polycythemia rubra vera maintained by approximately 18 stochastic stem-cell divisions per year, explaining age of onset by a single rate-limiting mutation

Blood. 2007 Sep 1;110(5):1675-80. doi: 10.1182/blood-2006-12-061911. Epub 2007 Apr 23.

Abstract

As the rates of most cancers are proportional to the fourth to fifth power of age ("log-log" behavior), it is widely believed that 5 to 6 independent mutations are necessary for malignant transformation. Conversely, the peak incidences of most cancers are similar to stem-cell mutation rates at single loci, implying only one rate-limiting mutation. Here, flow cytometrically measured red blood cells mutated at a selectively neutral locus, glycophorin A, allow observation of individual stem-cell differentiation events in a log-log malignancy, polycythemia rubra vera. Contrary to predictions from multistep models, the clone is driven by infrequent (< annual) and rare ( approximately 18 per year) differentiation events. These parameters imply that malignant stem cells have a modest selective advantage. Correspondingly minor, typically less than 20%, increases in stochastic self-renewal ratios are modeled to show that single mutations can result in the observed fourth power relationship with age. The conundrum between log-log behavior and mutation rate is thereby reconcilable, with the age of onset arising not from the requirement for multiple, independent mutations but from infrequent, stochastic stem-cell division rates and single mutations causing initially minor effects, but initiating a clone whose expected number increases successively with age--an "exponential phenotype."

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age of Onset
  • Aged
  • Amino Acid Substitution
  • Cell Differentiation / genetics
  • Cell Division / genetics*
  • Glycophorins / genetics*
  • Humans
  • Janus Kinase 2 / genetics*
  • Janus Kinase 2 / metabolism
  • Mutation, Missense*
  • Neoplastic Stem Cells* / metabolism
  • Polycythemia Vera / genetics*
  • Polycythemia Vera / physiopathology
  • Quantitative Trait Loci / genetics*
  • Time Factors

Substances

  • Glycophorins
  • JAK2 protein, human
  • Janus Kinase 2